Struma ovarii other imaging findings

Struma ovarii Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Struma ovarii from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
ECG
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Struma ovarii other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Struma ovarii other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Struma ovarii other imaging findings
CDC on Struma ovarii other imaging findings
Struma ovarii other imaging findings in the news
Blogs on Struma ovarii other imaging findings
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Struma ovarii other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

• There are no other imaging findings associated with [disease name].

• [Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Imaging Findings

• Scintigraphy may be helpful in the diagnosis of Struma ovarii.

(a) Whole-body I-123 imaging shows significantly increased I-123 uptake within the left hemi-pelvis in a 61-year-old woman with a history of thyrotoxicosis treated with radioiodine treatment twice over the last 30 years, who ultimately had a thyroidectomy which showed Graves disease but who remained thyrotoxic post surgery. (b) The area of increased uptake within the left hemi pelvis corresponds on the low-dose CT to an 8-cm left-sided pelvic mass (M) in keeping with a confirmed struma ovarii